Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1256]

SIOG 2024: Updates in medical oncology

Dr Capucine Baldini - Gustave Roussy, Villejuif, France

SIOG 2024: Updates in medical oncology ( Dr Capucine Baldini - Gustave Roussy, Villejuif, France )

ASCO GU 2025: Latest updates in mRCC

Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto...

ASCO GU 2025: Latest updates in mRCC ( Dr Bradley McGregor, Dr Stephanie Berg, Prof Viktor Grünwald and Prof Roberto Iacovelli )

Enhancing medicine safety monitoring in Zambia

Mulubwa Chilambe - Zambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia

Enhancing medicine safety monitoring in Zambia ( Mulubwa Chilambe - Zambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia )

The evolution of pharmacovigilance: Lessons from thalidomide

Sihle Mchunu - Novartis, Johannesburg, South Africa

The evolution of pharmacovigilance: Lessons from thalidomide ( Sihle Mchunu - Novartis, Johannesburg, South Africa )

Understanding pharmacovigilance challenges in Lesotho & Swaziland

Ntiyiso Vision - Abbott, Johannesburg, South Africa

Understanding pharmacovigilance challenges in Lesotho & Swaziland ( Ntiyiso Vision - Abbott, Johannesburg, South Africa )

Advances in pharmacovigilance in Nigeria

Dr Elemuwa Uchenna G - Pharmacovigilance National Agency for Food and Drug...

Advances in pharmacovigilance in Nigeria ( Dr Elemuwa Uchenna G - Pharmacovigilance National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria )

Understanding pharmacovigilance in Namibia

Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia

Understanding pharmacovigilance in Namibia ( Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia )

Advancements in pharmacovigilance in East Africa

Felix Mochache - Novartis, Nairobi, Kenya

Advancements in pharmacovigilance in East Africa ( Felix Mochache - Novartis, Nairobi, Kenya )

Understanding the role of the Tanzania Medicines and Medical Devices Authority

Damas Matiko - Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma...

Understanding the role of the Tanzania Medicines and Medical Devices Authority ( Damas Matiko - Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania )

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed...

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston...

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )

Optimising immunoglobulin dosing can enhance patient outcomes in multiple...

Dr Elizabeth O'Donnell - Dana-Farber Cancer Institute, Boston, USA

Optimising immunoglobulin dosing can enhance patient outcomes in multiple myeloma ( Dr Elizabeth O'Donnell - Dana-Farber Cancer Institute, Boston, USA )

Targeted therapies associated with increased risk for and incidence of...

Dr James Martin - Cleveland Clinic, Cleveland, USA

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer ( Dr James Martin - Cleveland Clinic, Cleveland, USA )

More from ecancer